Akèy › Sendwòm myelodisplastik › Florid
Etid klinik pou Sendwòm myelodisplastik nan Florid
31 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan Florid.
Vil nan Florid
Tèks ofisyèl etid la (Anglè)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- UF Health Cancer Institute - Gainesville, Gainesville
- Miami Cancer Institute, Miami
- Memorial Hospital West, Pembroke Pines
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06577441The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 12 a 78 · Tout sèks · Mizajou Sep 29, 2026 · NCT03802695MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- UF Health Cancer Institute - Gainesville, Gainesville
- Mayo Clinic in Florida, Jacksonville
- Miami Cancer Institute, Miami
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Mayo Clinic Jacksonville, Jacksonville
- Sylvester Cancer Center - U Miami, Miami
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- University of Miami, Miami
- BRCR Medical Center Inc, Tamarac
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07422480A Study of BGB-11417 in Participants With Myeloid Malignancies
- Tampa General Hospital, Tampa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT04771130A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- University of Miami, Miami
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06566742A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06616636The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Broward Health Medical Center, Fort Lauderdale
- Golisano Children's Hospital of Southwest Florida, Fort Myers
- UF Health Cancer Institute - Gainesville, Gainesville
- ak 9 plis
Ap rekriteFaz 1/2
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- University of Miami Hospital and Clinics, Miami
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- University of Miami School of Medicine Sylvester Comprehensive Cancer Center (SCCC), Miami
- H. Lee Moffitt Cancer Center and Research Center, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT04419649ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06656494eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
- University of Miami, Miami
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07469592Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
- University of Miami, Miami
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT05308264Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- University of Florida, Gainesville
Ap rekriteFaz 2
6 Months – 39 Years · Tout sèks · Mizajou Jun 4, 2026 · NCT05800210A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Mayo Clinic in Florida, Jacksonville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT05969860A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Mayo Clinic Florida, Jacksonville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT05732103A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- University of Miami, Miami
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 2
Laj 1 a 60 · Tout sèks · Mizajou Mar 12, 2026 · NCT03970096Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Sylvester Comprehensive Cancer Center, Miami
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 20, 2026 · NCT05745285CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- University of Miami Health System, Miami
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05143996Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Mayo Clinic, Jacksonville
- University of Miami, Miami
- AdventHealth Medical Group & Bone Marrow Transplant at Orlando, Orlando
- ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 23, 2025 · NCT04245397SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT06501196Study of REM-422 in Patients With AML or Higher Risk MDS
- Moffitt Cancer Center, Tampa
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2025 · NCT06297941The International PNH Interest Group PNH Registry
- International PNH Interest Group, Altamonte Springs
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 29, 2024 · NCT06524726Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
- Mayo Clinic Cancer Center, Jacksonville
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 9, 2020 · NCT04167696A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- H. Lee Moffitt Cancer Center & Research Institute, Tampa
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2019 · NCT03886662Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.